why choose us

First received: December 01, 2022

Clinical Trial: Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Alzheimer Disease

Study Type: INTERVENTIONAL


Official Title: Ph 1, Open-Label Safety Study of Escalating Doses of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous ADSCs in Participants With Mild-Moderate AD Whose Treatment is Not Addressed Ade

Brief Summary: This is a research study to evaluate the safety of an investigational autologous cell product obtained from participant's own adipose tissue as a possible treatment for Alzheimer disease.

Read more